{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "11/03/2025",
      "update_type": "New",
      "initial_posting_date": "11/03/2025",
      "package_ndc": "45802-580-46",
      "generic_name": "Scopolamine Transdermal System",
      "contact_info": "866-634-9120",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "ANDA078830"
        ],
        "brand_name": [
          "SCOPOLAMINE TRANSDERMAL SYSTEM"
        ],
        "generic_name": [
          "SCOPOLAMINE TRANSDERMAL SYSTEM"
        ],
        "manufacturer_name": [
          "Padagis Israel Pharmaceuticals Ltd"
        ],
        "product_ndc": [
          "45802-580"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TRANSDERMAL"
        ],
        "substance_name": [
          "SCOPOLAMINE"
        ],
        "rxcui": [
          "226552"
        ],
        "spl_id": [
          "d334a21d-7546-477f-a66a-f95b2cf523ce"
        ],
        "spl_set_id": [
          "cb93bfad-3e37-4a27-92f6-f21703ae7bdf"
        ],
        "package_ndc": [
          "45802-580-84",
          "45802-580-46",
          "45802-580-62",
          "45802-580-01"
        ],
        "nui": [
          "N0000175574",
          "N0000175370"
        ],
        "pharm_class_epc": [
          "Anticholinergic [EPC]"
        ],
        "pharm_class_moa": [
          "Cholinergic Antagonists [MoA]"
        ],
        "unii": [
          "DL48G20X8X"
        ]
      },
      "update_date": "11/03/2025",
      "therapeutic_category": [
        "Gastroenterology",
        "Neurology",
        "Other"
      ],
      "dosage_form": "Transdermal System",
      "presentation": "Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)",
      "company_name": "Padagis US LLC",
      "status": "To Be Discontinued"
    }
  ]
}